Medicenna Therapeutics Corp. Announces A Poster Presentation and an Oral Summary Highlighting Long-term Follow-up Up Results from the Phase 2b Clinical Trial of Bizaxofusp
Medicenna Therapeutics Corp. announced that a poster presentation and an oral summary highlighting longer term follow up results from the Phase 2b clinical trial of bizaxofusp , the Companys...
British Columbia Steven Brem Centre For Precision Surgery Society For Neuro Abramson Cancer Center Perelman School Of Medicine
Source: marketscreener.com